PRRT2 and melanoma: CHE critically affects mitochondria and malignancies in melanoma CSCs and is well recognized as a potent inhibitor of protein kinase C (PKC) for isoforms α and β. However, its effect on normal cells is still missing and worth investigating in further studies.